Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in DogsDavid L. Mack, Martin K. Childers, Valerie E. Kelly et al.|Molecular Therapy|2017Cited by 109
Tissue Triage and Freezing for Models of Skeletal Muscle DiseaseHui Meng, Michael W. Lawlor, Paul M.L. Janssen et al.|Journal of Visualized Experiments|2014Cited by 98
Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathyMichael W. Lawlor, Alan H. Beggs, Dustin Armstrong et al.|Human Molecular Genetics|2013Cited by 82
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophySharla M. Birch, Joe N. Kornegay, Michael W. Lawlor et al.|Science Translational Medicine|2023Cited by 68
Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species ComparisonsMichael W. Lawlor, Caroline A. Sewry, Alan H. Beggs et al.|Journal of Neuropathology & Experimental Neurology|2016Cited by 66